# Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

> **NCT00307502** · PHASE1 · COMPLETED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 675 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Efavirenz
- **DRUG:** Indinavir/ritonavir
- **DRUG:** Nelfinavir
- **DRUG:** Saquinavir/ritonavir
- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Atazanavir
- **DRUG:** Atazanavir/ritonavir
- **DRUG:** Fos-amprenavir/ritonavir
- **DRUG:** Tipranavir/ ritonavir
- **DRUG:** Darunavir/ritonavir

## Key facts

- **NCT ID:** NCT00307502
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 675 (ACTUAL)
- **Last updated:** 2019-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307502, "Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00307502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*